Local response (no local response) | OR | 95 % CI (OR) | p-value |
Arm (A – reference) | 0.033 | 0.004 – 0.311 | 0.003 |
PYD | 1.000 | 0.992 – 1.008 | 0.986 |
DPD | 1.023 | 0.974 – 1.074 | 0.371 |
CTX-I | 10.550 | 0.003 – >100 | 0.569 |
BAP | 1.011 | 0.996 – 1.025 | 0.142 |
NTX | 0.870 | 0.688 – 1.101 | 0.245 |
PINP | 0.968 | 0.938 – 0.999 | 0.043 |
Prevention of SRE (SRE = 0) | OR | 95 % CI (OR) | p-value |
Arm (A – reference) | 3.302 | 0.877 – 12.431 | 0.077 |
PYD | 0.998 | 0.994 – 1.002 | 0.373 |
DPD | 1.006 | 0.982 – 1.031 | 0.633 |
CTX-I | 0.323 | 0.001 – 81.336 | 0.689 |
BAP | 0.974 | 0.950 – 0.998 | 0.034 |
NTX | 0.988 | 0.861 – 1.134 | 0.865 |
PINP | 1.025 | 1.001 – 1.049 | 0.044 |
Solitary metastasis (n = 1) | OR | 95 % CI (OR) | p-value |
Arm (A – reference) | 1.692 | 0.477 – 6.007 | 0.416 |
PYD | 1.001 | 0.997 – 1.005 | 0.512 |
DPD | 1.004 | 0.980 – 1.029 | 0.761 |
CTX-I | 0.359 | 0.001 – >100 | 0.723 |
BAP | 0.997 | 0.985 – 1.009 | 0.592 |
NTX | 1.083 | 0.939 – 1.249 | 0.275 |
PINP | 0.998 | 0.981 – 1.016 | 0.829 |